GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 02/08/2011
PIL Amoxil Paediatric Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change of inactive ingredient
  • Change to packaging
Updated on 22/12/2010 and displayed until 02/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 04/03/2010 and displayed until 22/12/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 01/12/2008 and displayed until 04/03/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Extra statutory information
  • Change due to user-testing of patient information
Updated on 21/03/2005 and displayed until 01/12/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change from the BAN of the active substance to the rINN
Updated on 19/07/2002 and displayed until 21/03/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   amoxicillin